Towards identification of true cancer biomarkers

被引：0
作者：
Eleftherios P Diamandis
机构：
[1] University of Toronto,Department of Laboratory Medicine and Pathobiology
[2] Mount Sinai Hospital,Department of Pathology and Laboratory Medicine
[3] University Health Network,Department of Clinical Biochemistry
[4] Mount Sinai Hospital,undefined
来源：
BMC Medicine | / 12卷
关键词：
Cancer biomarker; Genomics; Proteomics; Mutant proteins; High specificity; Selected reaction monitoring; Mass spectrometry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 119 条
  • [1] Diamandis EP(2008)National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the use of tumor markers Clin Chem 54 1935-1939
  • [2] Hoffman BR(2010)Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer Nat Rev Cancer 10 371-378
  • [3] Sturgeon CM(2010)Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst 102 1462-1467
  • [4] Kulasingam V(2004)Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems J Natl Cancer Inst 96 353-356
  • [5] Pavlou MP(2012)Intratumor heterogeneity: seeing the wood for the trees Sci Transl Med 4 127-432
  • [6] Diamandis EP(2011)Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis Pathology 43 420-432
  • [7] Diamandis EP(2011)Cancer: Missing the mark Nature 471 428-339
  • [8] Diamandis EP(2013)Mutational landscape and significance across 12 major cancer types Nature 502 333-307
  • [9] Yap TA(2013)Genomics: Comparisons across cancers Nature 502 306-9535
  • [10] Gerlinger M(2013)Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers Sci Transl Med 5 167ra4-1619
12345678910